468 related articles for article (PubMed ID: 29299635)
1. Both conditional ablation and overexpression of E2 SUMO-conjugating enzyme (UBC9) in mouse pancreatic beta cells result in impaired beta cell function.
He X; Lai Q; Chen C; Li N; Sun F; Huang W; Zhang S; Yu Q; Yang P; Xiong F; Chen Z; Gong Q; Ren B; Weng J; Eizirik DL; Zhou Z; Wang CY
Diabetologia; 2018 Apr; 61(4):881-895. PubMed ID: 29299635
[TBL] [Abstract][Full Text] [Related]
2. A post-translational balancing act: the good and the bad of SUMOylation in pancreatic islets.
MacDonald PE
Diabetologia; 2018 Apr; 61(4):775-779. PubMed ID: 29330559
[TBL] [Abstract][Full Text] [Related]
3. NRF2 is required for neonatal mouse beta cell growth by maintaining redox balance and promoting mitochondrial biogenesis and function.
Baumel-Alterzon S; Katz LS; Lambertini L; Tse I; Heidery F; Garcia-Ocaña A; Scott DK
Diabetologia; 2024 Mar; 67(3):547-560. PubMed ID: 38206362
[TBL] [Abstract][Full Text] [Related]
4. Loss of ubiquitin-conjugating enzyme E2 (Ubc9) in macrophages exacerbates multiple low-dose streptozotocin-induced diabetes by attenuating M2 macrophage polarization.
Wang F; Sun F; Luo J; Yue T; Chen L; Zhou H; Zhang J; Yang C; Luo X; Zhou Q; Zhu H; Li J; Yang P; Xiong F; Yu Q; Zhang H; Zhang W; Xu A; Zhou Z; Lu Q; Eizirik DL; Zhang S; Wang CY
Cell Death Dis; 2019 Nov; 10(12):892. PubMed ID: 31767832
[TBL] [Abstract][Full Text] [Related]
5. The SUMO conjugating enzyme Ubc9 is required for inducing and maintaining stem cell pluripotency.
Tahmasebi S; Ghorbani M; Savage P; Gocevski G; Yang XJ
Stem Cells; 2014 Apr; 32(4):1012-20. PubMed ID: 24706591
[TBL] [Abstract][Full Text] [Related]
6. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae.
Klug H; Xaver M; Chaugule VK; Koidl S; Mittler G; Klein F; Pichler A
Mol Cell; 2013 Jun; 50(5):625-36. PubMed ID: 23644018
[TBL] [Abstract][Full Text] [Related]
7. Site-specific inhibition of the small ubiquitin-like modifier (SUMO)-conjugating enzyme Ubc9 selectively impairs SUMO chain formation.
Wiechmann S; Gärtner A; Kniss A; Stengl A; Behrends C; Rogov VV; Rodriguez MS; Dötsch V; Müller S; Ernst A
J Biol Chem; 2017 Sep; 292(37):15340-15351. PubMed ID: 28784659
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
[TBL] [Abstract][Full Text] [Related]
9. UBC9-Mediated Sumoylation Favorably Impacts Cardiac Function in Compromised Hearts.
Gupta MK; McLendon PM; Gulick J; James J; Khalili K; Robbins J
Circ Res; 2016 Jun; 118(12):1894-905. PubMed ID: 27142163
[TBL] [Abstract][Full Text] [Related]
10. An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency.
López I; Chalatsi E; Ellenbroek SIJ; Andrieux A; Roux PF; Cerapio JP; Jouvion G; van Rheenen J; Seeler JS; Dejean A
Oncogene; 2020 Oct; 39(43):6692-6703. PubMed ID: 32948837
[TBL] [Abstract][Full Text] [Related]
11. Nrf2 protects pancreatic β-cells from oxidative and nitrosative stress in diabetic model mice.
Yagishita Y; Fukutomi T; Sugawara A; Kawamura H; Takahashi T; Pi J; Uruno A; Yamamoto M
Diabetes; 2014 Feb; 63(2):605-18. PubMed ID: 24186865
[TBL] [Abstract][Full Text] [Related]
12. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes.
Bossis G; Melchior F
Mol Cell; 2006 Feb; 21(3):349-57. PubMed ID: 16455490
[TBL] [Abstract][Full Text] [Related]
13. Is Transthyretin a Regulator of Ubc9 SUMOylation?
Wieczorek E; Kędracka-Krok S; Sołtys K; Jankowska U; Hołubowicz R; Seliga J; Ożyhar A
PLoS One; 2016; 11(8):e0160536. PubMed ID: 27501389
[TBL] [Abstract][Full Text] [Related]
14. Protein SUMOylation Is Required for Regulatory T Cell Expansion and Function.
Ding X; Wang A; Ma X; Demarque M; Jin W; Xin H; Dejean A; Dong C
Cell Rep; 2016 Jul; 16(4):1055-1066. PubMed ID: 27425617
[TBL] [Abstract][Full Text] [Related]
15. MEL-18 interacts with HSF2 and the SUMO E2 UBC9 to inhibit HSF2 sumoylation.
Zhang J; Goodson ML; Hong Y; Sarge KD
J Biol Chem; 2008 Mar; 283(12):7464-9. PubMed ID: 18211895
[TBL] [Abstract][Full Text] [Related]
16. Protective Role of Nuclear Factor E2-Related Factor 2 against Acute Oxidative Stress-Induced Pancreatic β -Cell Damage.
Fu J; Zheng H; Wang H; Yang B; Zhao R; Lu C; Liu Z; Hou Y; Xu Y; Zhang Q; Qu W; Pi J
Oxid Med Cell Longev; 2015; 2015():639191. PubMed ID: 25949772
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into the regulation of the human E2∼SUMO conjugate through analysis of its stable mimetic.
Goffinont S; Coste F; Prieu-Serandon P; Mance L; Gaudon V; Garnier N; Castaing B; Suskiewicz MJ
J Biol Chem; 2023 Jul; 299(7):104870. PubMed ID: 37247759
[TBL] [Abstract][Full Text] [Related]
18. Effect of endosulfan and bisphenol A on the expression of SUMO and UBC9.
Yarahalli Jayaram V; Baggavalli S; Reddy D; Sistla S; Malempati R
Drug Chem Toxicol; 2020 Nov; 43(6):637-644. PubMed ID: 30426790
[TBL] [Abstract][Full Text] [Related]
19. Sumo E2 enzyme UBC9 is required for efficient protein quality control in cardiomyocytes.
Gupta MK; Gulick J; Liu R; Wang X; Molkentin JD; Robbins J
Circ Res; 2014 Sep; 115(8):721-9. PubMed ID: 25097219
[TBL] [Abstract][Full Text] [Related]
20. Rhes, a physiologic regulator of sumoylation, enhances cross-sumoylation between the basic sumoylation enzymes E1 and Ubc9.
Subramaniam S; Mealer RG; Sixt KM; Barrow RK; Usiello A; Snyder SH
J Biol Chem; 2010 Jul; 285(27):20428-32. PubMed ID: 20424159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
